Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

HAYWARD, Calif., June 10, 2025--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been predicting ...

Gilead and Arcus entered into a $2 billion alliance in 2021 in which Gilead exercised options on four drug candidates, including domvanalimab, follow-up TIGIT AB308, adenosine A2a/A2b receptor ...

Patrick Agyemang scored a late goal in the U.S. men's national team's 2-1 win over Haiti on Sunday, ensuring they ended ...

The future of fluidics in healthcare: Blake Webb shares trends in automation and microfluidics that are reshaping medical diagnostics and laboratory processes.

Cuban diplomat defends foreign medical missions under pressure from US Cuban doctors arrive at the Jose Marti International Airport in Havana, Cuba, June 8, 2020, after traveling to Italy to help ...

Logos plans to begin deploying satellites in late 2027, pending FCC approvals. Credit: Logos Space Services TAMPA, Fla. — Logos Space Services has raised $50 million to advance engineering plans ...

A recent study published in Macromolecular Materials and Engineering presents a new method for creating antimicrobial polymer blends designed for 3D printing. The approach addresses a growing need in ...

During Wednesday night’s "NBA Countdown" on ABC, NBA commissioner Adam Silver responded to criticism of the digitally inserted images of the Larry O’Brien Trophy shown on the court during the ...

Arcus Biosciences Inc. Annual cash flow by MarketWatch. View RCUS net cash flow, operating cash flow, operating expenses and cash dividends.